Methyl Undecylenate is a linear ester with a terminal double bond, that can be used as a chemical intermediate in the synthesis of aromatic chemicals, of polymers or modified silicones. Methyl undecylenate is produced by fractional distillation of the product obtained by the pyrolysis of methyl ricinoleate at a high temperature. Methyl undecylenate is used as a chemical intermediate in the synthesis of organo-modified silicones for hair care preparations and sun care products. It can also be used as a chemical intermediate for synthesizing derivatives based on ammonium or ethanolamide used in hair-care products.

Imidazole salicylate (also known as ITF-182), a nonsteroidal anti-inflammatory drug (NSAID) that inhibits Tromboxane A2 synthesis, without interfering with cyclo-oxygenase pathway and possesses the limited inhibitory effects on prostaglandin synthesis. Imidazole salicylate can be used for the treatment of osteoarthrosis and musculoskeletal trauma. In addition, it can be given to patients with decompensated cirrhosis without risk of inhibiting kidney prostaglandin synthesis. Imidazole salicylate was characterized by good gastric tolerability and could be assigned for treatment of rheumatic diseases in the elderly. The drug also can be safely used in aspirin-sensitive patients.